The regulatory environment for peptide research is evolving rapidly across multiple jurisdictions.
Global Overview
Key regulatory developments in 2026 include updated classification frameworks in the EU, new import/export protocols in Asia-Pacific, and expanded research exemptions in North America.
Compliance Implications
Researchers and institutions must stay current with rapidly changing regulations. Documentation requirements have increased, but research access has generally been preserved or expanded.
